Primary mediastinal B-cell lymphoma · 4 regimens
Cost vs Efficacy · 2 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
R-CHOP Variant #23 | — | R 59 865 | 21d | ~14.4 mo | ~55.7 mo | ~21 | ~R 1 257 163 PFS proxy · indirect | 11 |
DA-R-EPOCH Variant #01 | — | R 13 318 | 21d | — | — | — | — | 1 |
R-CHOP-14 (Prednisolone) Variant #01 | — | R 12 674 | 14d | — | — | — | — | 1 |
R-CHOP (Prednisolone) Variant #01 | — | R 12 666 | 21d | ~42.4 mo | — | ~62 | ~R 785 263 PFS proxy · indirect | — |
4 of 4 regimens shown